TRANSCAT INC (TRNS) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:TRNS • US8935291075

76.33 USD
+5.93 (+8.42%)
At close: Feb 6, 2026
76.33 USD
0 (0%)
After Hours: 2/6/2026, 8:09:06 PM
Fundamental Rating

5

TRNS gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 50 industry peers in the Trading Companies & Distributors industry. TRNS has an average financial health and profitability rating. TRNS is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • In the past year TRNS was profitable.
  • In the past year TRNS had a positive cash flow from operations.
  • In the past 5 years TRNS has always been profitable.
  • In the past 5 years TRNS always reported a positive cash flow from operatings.
TRNS Yearly Net Income VS EBIT VS OCF VS FCFTRNS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 2.34%, TRNS is in line with its industry, outperforming 42.00% of the companies in the same industry.
  • With a Return On Equity value of 3.84%, TRNS is not doing good in the industry: 62.00% of the companies in the same industry are doing better.
  • TRNS's Return On Invested Capital of 3.29% is on the low side compared to the rest of the industry. TRNS is outperformed by 64.00% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for TRNS is below the industry average of 9.60%.
Industry RankSector Rank
ROA 2.34%
ROE 3.84%
ROIC 3.29%
ROA(3y)4.66%
ROA(5y)5.25%
ROE(3y)7.28%
ROE(5y)9.09%
ROIC(3y)6%
ROIC(5y)6.74%
TRNS Yearly ROA, ROE, ROICTRNS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

1.3 Margins

  • The Profit Margin of TRNS (3.75%) is comparable to the rest of the industry.
  • TRNS's Profit Margin has improved in the last couple of years.
  • TRNS has a Operating Margin of 6.39%. This is comparable to the rest of the industry: TRNS outperforms 52.00% of its industry peers.
  • TRNS's Operating Margin has improved in the last couple of years.
  • TRNS has a Gross Margin (32.45%) which is comparable to the rest of the industry.
  • TRNS's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 6.39%
PM (TTM) 3.75%
GM 32.45%
OM growth 3Y-2.14%
OM growth 5Y1.69%
PM growth 3Y-2.08%
PM growth 5Y2.27%
GM growth 3Y4.06%
GM growth 5Y5.54%
TRNS Yearly Profit, Operating, Gross MarginsTRNS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), TRNS is destroying value.
  • The number of shares outstanding for TRNS has been increased compared to 1 year ago.
  • TRNS has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, TRNS has a worse debt to assets ratio.
TRNS Yearly Shares OutstandingTRNS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M
TRNS Yearly Total Debt VS Total AssetsTRNS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

2.2 Solvency

  • TRNS has an Altman-Z score of 3.24. This indicates that TRNS is financially healthy and has little risk of bankruptcy at the moment.
  • TRNS has a Altman-Z score (3.24) which is comparable to the rest of the industry.
  • The Debt to FCF ratio of TRNS is 4.45, which is a neutral value as it means it would take TRNS, 4.45 years of fcf income to pay off all of its debts.
  • TRNS has a Debt to FCF ratio of 4.45. This is in the better half of the industry: TRNS outperforms 62.00% of its industry peers.
  • TRNS has a Debt/Equity ratio of 0.38. This is a healthy value indicating a solid balance between debt and equity.
  • The Debt to Equity ratio of TRNS (0.38) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF 4.45
Altman-Z 3.24
ROIC/WACC0.33
WACC9.85%
TRNS Yearly LT Debt VS Equity VS FCFTRNS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M

2.3 Liquidity

  • A Current Ratio of 2.43 indicates that TRNS has no problem at all paying its short term obligations.
  • TRNS has a Current ratio of 2.43. This is in the better half of the industry: TRNS outperforms 64.00% of its industry peers.
  • TRNS has a Quick Ratio of 2.06. This indicates that TRNS is financially healthy and has no problem in meeting its short term obligations.
  • TRNS has a Quick ratio of 2.06. This is in the better half of the industry: TRNS outperforms 76.00% of its industry peers.
Industry RankSector Rank
Current Ratio 2.43
Quick Ratio 2.06
TRNS Yearly Current Assets VS Current LiabilitesTRNS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • The earnings per share for TRNS have decreased by -9.19% in the last year.
  • TRNS shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 6.36% yearly.
  • Looking at the last year, TRNS shows a small growth in Revenue. The Revenue has grown by 7.30% in the last year.
  • The Revenue has been growing by 9.97% on average over the past years. This is quite good.
EPS 1Y (TTM)-9.19%
EPS 3Y-2.79%
EPS 5Y6.36%
EPS Q2Q%4%
Revenue 1Y (TTM)7.3%
Revenue growth 3Y10.75%
Revenue growth 5Y9.97%
Sales Q2Q%25.63%

3.2 Future

  • The Earnings Per Share is expected to grow by 19.42% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 9.30% on average over the next years. This is quite good.
EPS Next Y35.31%
EPS Next 2Y27.15%
EPS Next 3Y16.78%
EPS Next 5Y19.42%
Revenue Next Year17.89%
Revenue Next 2Y12.65%
Revenue Next 3Y9.23%
Revenue Next 5Y9.3%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
TRNS Yearly Revenue VS EstimatesTRNS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 100M 200M 300M 400M
TRNS Yearly EPS VS EstimatesTRNS Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3

More info and screens

Find the best growth stocksShow best growing peers

3

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 45.43, the valuation of TRNS can be described as expensive.
  • 60.00% of the companies in the same industry are cheaper than TRNS, based on the Price/Earnings ratio.
  • The average S&P500 Price/Earnings ratio is at 27.92. TRNS is valued rather expensively when compared to this.
  • Based on the Price/Forward Earnings ratio of 32.12, the valuation of TRNS can be described as expensive.
  • The rest of the industry has a similar Price/Forward Earnings ratio as TRNS.
  • When comparing the Price/Forward Earnings ratio of TRNS to the average of the S&P500 Index (27.78), we can say TRNS is valued inline with the index average.
Industry RankSector Rank
PE 45.43
Fwd PE 32.12
TRNS Price Earnings VS Forward Price EarningsTRNS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as TRNS.
  • Based on the Price/Free Cash Flow ratio, TRNS is valued a bit cheaper than the industry average as 74.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 28.33
EV/EBITDA 18.41
TRNS Per share dataTRNS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

  • TRNS's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • TRNS's earnings are expected to grow with 16.78% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.29
PEG (5Y)7.14
EPS Next 2Y27.15%
EPS Next 3Y16.78%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • TRNS does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

TRANSCAT INC

NASDAQ:TRNS (2/6/2026, 8:09:06 PM)

After market: 76.33 0 (0%)

76.33

+5.93 (+8.42%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryTrading Companies & Distributors
Earnings (Last)02-03
Earnings (Next)05-18
Inst Owners98.89%
Inst Owner Change0.17%
Ins Owners0.99%
Ins Owner Change0.9%
Market Cap712.16M
Revenue(TTM)278.42M
Net Income(TTM)11.35M
Analysts80
Price Target105.74 (38.53%)
Short Float %4.81%
Short Ratio3.58
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)15.93%
Min EPS beat(2)-14.58%
Max EPS beat(2)46.44%
EPS beat(4)2
Avg EPS beat(4)2.63%
Min EPS beat(4)-24%
Max EPS beat(4)46.44%
EPS beat(8)5
Avg EPS beat(8)8.39%
EPS beat(12)7
Avg EPS beat(12)3.58%
EPS beat(16)8
Avg EPS beat(16)2.32%
Revenue beat(2)2
Avg Revenue beat(2)2.55%
Min Revenue beat(2)1.44%
Max Revenue beat(2)3.66%
Revenue beat(4)2
Avg Revenue beat(4)-0.71%
Min Revenue beat(4)-6.92%
Max Revenue beat(4)3.66%
Revenue beat(8)4
Avg Revenue beat(8)-1.54%
Revenue beat(12)5
Avg Revenue beat(12)-1.13%
Revenue beat(16)7
Avg Revenue beat(16)-0.89%
PT rev (1m)0%
PT rev (3m)-6.94%
EPS NQ rev (1m)-8.13%
EPS NQ rev (3m)-19.43%
EPS NY rev (1m)-4.72%
EPS NY rev (3m)-10.52%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)3.03%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.44%
Valuation
Industry RankSector Rank
PE 45.43
Fwd PE 32.12
P/S 2.35
P/FCF 28.33
P/OCF 17.93
P/B 2.41
P/tB N/A
EV/EBITDA 18.41
EPS(TTM)1.68
EY2.2%
EPS(NY)2.38
Fwd EY3.11%
FCF(TTM)2.69
FCFY3.53%
OCF(TTM)4.26
OCFY5.58%
SpS32.43
BVpS31.66
TBVpS-0.87
PEG (NY)1.29
PEG (5Y)7.14
Graham Number34.6
Profitability
Industry RankSector Rank
ROA 2.34%
ROE 3.84%
ROCE 4.3%
ROIC 3.29%
ROICexc 3.33%
ROICexgc 10.5%
OM 6.39%
PM (TTM) 3.75%
GM 32.45%
FCFM 8.31%
ROA(3y)4.66%
ROA(5y)5.25%
ROE(3y)7.28%
ROE(5y)9.09%
ROIC(3y)6%
ROIC(5y)6.74%
ROICexc(3y)6.37%
ROICexc(5y)6.98%
ROICexgc(3y)14.95%
ROICexgc(5y)15.39%
ROCE(3y)7.84%
ROCE(5y)8.8%
ROICexgc growth 3Y-9.42%
ROICexgc growth 5Y-3.25%
ROICexc growth 3Y-18.51%
ROICexc growth 5Y-11.8%
OM growth 3Y-2.14%
OM growth 5Y1.69%
PM growth 3Y-2.08%
PM growth 5Y2.27%
GM growth 3Y4.06%
GM growth 5Y5.54%
F-Score3
Asset Turnover0.62
Health
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF 4.45
Debt/EBITDA 2.7
Cap/Depr 65.9%
Cap/Sales 4.82%
Interest Coverage 250
Cash Conversion 95.79%
Profit Quality 221.43%
Current Ratio 2.43
Quick Ratio 2.06
Altman-Z 3.24
F-Score3
WACC9.85%
ROIC/WACC0.33
Cap/Depr(3y)85.02%
Cap/Depr(5y)89.69%
Cap/Sales(3y)4.65%
Cap/Sales(5y)4.54%
Profit Quality(3y)129.96%
Profit Quality(5y)134.79%
High Growth Momentum
Growth
EPS 1Y (TTM)-9.19%
EPS 3Y-2.79%
EPS 5Y6.36%
EPS Q2Q%4%
EPS Next Y35.31%
EPS Next 2Y27.15%
EPS Next 3Y16.78%
EPS Next 5Y19.42%
Revenue 1Y (TTM)7.3%
Revenue growth 3Y10.75%
Revenue growth 5Y9.97%
Sales Q2Q%25.63%
Revenue Next Year17.89%
Revenue Next 2Y12.65%
Revenue Next 3Y9.23%
Revenue Next 5Y9.3%
EBIT growth 1Y-18.82%
EBIT growth 3Y8.38%
EBIT growth 5Y11.83%
EBIT Next Year206.57%
EBIT Next 3Y48.89%
EBIT Next 5Y35.49%
FCF growth 1Y42.8%
FCF growth 3Y51.16%
FCF growth 5Y38.93%
OCF growth 1Y43.49%
OCF growth 3Y30.31%
OCF growth 5Y27.52%

TRANSCAT INC / TRNS FAQ

What is the fundamental rating for TRNS stock?

ChartMill assigns a fundamental rating of 5 / 10 to TRNS.


Can you provide the valuation status for TRANSCAT INC?

ChartMill assigns a valuation rating of 3 / 10 to TRANSCAT INC (TRNS). This can be considered as Overvalued.


What is the profitability of TRNS stock?

TRANSCAT INC (TRNS) has a profitability rating of 5 / 10.


Can you provide the PE and PB ratios for TRNS stock?

The Price/Earnings (PE) ratio for TRANSCAT INC (TRNS) is 45.43 and the Price/Book (PB) ratio is 2.41.


What is the financial health of TRANSCAT INC (TRNS) stock?

The financial health rating of TRANSCAT INC (TRNS) is 6 / 10.